BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang J, Sun Y, Bertagnolli MM. Comparison of gastric cancer survival between Caucasian and Asian patients treated in the United States: results from the Surveillance Epidemiology and End Results (SEER) database. Ann Surg Oncol. 2015;22:2965-2971. [PMID: 25631065 DOI: 10.1245/s10434-015-4388-4] [Cited by in Crossref: 45] [Cited by in F6Publishing: 53] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Klempner SJ, Bhangoo MS, Luu HY, Kim ST, Chao J, Kim KM, Lee J. Low ATM expression and progression-free and overall survival in advanced gastric cancer patients treated with first-line XELOX chemotherapy. J Gastrointest Oncol 2018;9:1198-206. [PMID: 30603142 DOI: 10.21037/jgo.2018.09.04] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Qiu M, Yang D, Xu R. Impact of marital status on survival of gastric adenocarcinoma patients: Results from the Surveillance Epidemiology and End Results (SEER) Database. Sci Rep 2016;6:21098. [PMID: 26876653 DOI: 10.1038/srep21098] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
3 Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14:26-38. [PMID: 30944675 DOI: 10.5114/pg.2018.80001] [Cited by in Crossref: 137] [Cited by in F6Publishing: 198] [Article Influence: 34.3] [Reference Citation Analysis]
4 Klapheke AK, Carvajal-Carmona LG, Cress RD. Racial/ethnic differences in survival among gastric cancer patients in california. Cancer Causes Control 2019;30:687-96. [PMID: 31102083 DOI: 10.1007/s10552-019-01184-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Uppal A, Dehal A, Chang SC, Barrak D, Naeini Y, Jalas JR, Bilchik AJ. The Immune Microenvironment Impacts Survival in Western Patients with Gastric Adenocarcinoma. J Gastrointest Surg 2020;24:28-38. [PMID: 31625020 DOI: 10.1007/s11605-019-04403-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Agolli L, Maurizi Enrici R, Osti MF. Adjuvant radiochemotherapy for gastric cancer: Should we use prognostic factors to select patients? World J Gastroenterol 2016; 22(3): 1131-1138 [PMID: 26811652 DOI: 10.3748/wjg.v22.i3.1131] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
7 Li W, Wang Z, Chen Y, Wang K, Lu T, Ying F, Fan M, Li Z, Wu J. Melatonin treatment induces apoptosis through regulating the nuclear factor-κB and mitogen-activated protein kinase signaling pathways in human gastric cancer SGC7901 cells. Oncol Lett 2017;13:2737-44. [PMID: 28454460 DOI: 10.3892/ol.2017.5785] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
8 Rhome RM, Ru M, Moshier E, Mazumdar M, Buckstein MH. Stage-matched survival differences by ethnicity among gastric cancer patients of Asian ancestry treated in the United States. J Surg Oncol 2019;119:737-48. [PMID: 30694524 DOI: 10.1002/jso.25389] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Balmagambetova SK, Bekmukhambetov YZ, Tulyaeva AB, Iztleuov YM, Smagulova GA, Koyshybaev AK, Urazayev ON, Djussembekov ST, Begunov VV, Kokhreidze I. Gastric Cancer in Aktobe Region of Western Kazakhstan from 2009 to 2018: Incidence Rates, Trends, and Five-Year Survival. Asian Pac J Cancer Prev 2020;21:1645-52. [PMID: 32592359 DOI: 10.31557/APJCP.2020.21.6.1645] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Liu H, Jin P, Ma FH, Ma S, Xie YB, Li Y, Li WK, Kang WZ, Tian YT. Feasibility and nutritional impact of laparoscopic assisted tailored subtotal gastrectomy for middle-third gastric cancer. World J Gastroenterol 2020; 26(43): 6837-6852 [PMID: 33268965 DOI: 10.3748/wjg.v26.i43.6837] [Reference Citation Analysis]
11 Yamaguchi K, Shimada Y, Hironaka S, Sugimoto N, Komatsu Y, Nishina T, Omuro Y, Tamura T, Piao Y, Homma G, Jen MH, Liepa AM, Muro K. Quality of Life Associated with Ramucirumab Treatment in Patients with Advanced Gastric Cancer in Japan: Exploratory Analysis from the Phase III RAINBOW Trial. Clin Drug Investig 2021;41:53-64. [PMID: 33355909 DOI: 10.1007/s40261-020-00979-3] [Reference Citation Analysis]
12 Xu X, Wei S, Chen Y, Yu D, Wang X, Dong X. Serum Small Proline-Rich Protein 2A (SPRR2A) Is a Noninvasive Biomarker in Gastric Cancer. Dis Markers 2020;2020:8493796. [PMID: 32908616 DOI: 10.1155/2020/8493796] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Li P, He HQ, Zhu CM, Ling YH, Hu WM, Zhang XK, Luo RZ, Yun JP, Xie D, Li YF, Cai MY. The prognostic significance of lymphovascular invasion in patients with resectable gastric cancer: a large retrospective study from Southern China. BMC Cancer 2015;15:370. [PMID: 25947284 DOI: 10.1186/s12885-015-1370-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
14 Zhao L, Niu P, Zhao D, Chen Y. Regional and racial disparity in proximal gastric cancer survival outcomes 1996-2016: Results from SEER and China National Cancer Center database. Cancer Med 2021;10:4923-38. [PMID: 34105890 DOI: 10.1002/cam4.4033] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Yang JR, Zhou DY, Wu Y, Zhu Y, Lin ZY, Zhang T, Yu DD. The prognostic value of baseline hematological parameters of peripheral blood in metastatic gastric cancer treated with apatinib. J Cancer 2022;13:15-20. [PMID: 34976167 DOI: 10.7150/jca.65339] [Reference Citation Analysis]
16 Chen FF, Huang DD, Lu JX, Zhou CJ, Zhuang CL, Wang SL, Shen X, Yu Z, Chen XL. Feasibility of Total Gastrectomy with D2 Lymphadenectomy for Gastric Cancer and Predictive Factors for Its Short- and Long-Term Outcomes. J Gastrointest Surg 2016;20:521-30. [PMID: 26691150 DOI: 10.1007/s11605-015-3059-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
17 Jing F, Hu X, Cao Y, Xu M, Wang Y, Jing Y, Hu X, Gao Y, Zhu Z. Discriminating gastric cancer and gastric ulcer using human plasma amino acid metabolic profile. IUBMB Life 2018;70:553-62. [PMID: 29626382 DOI: 10.1002/iub.1748] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
18 Zhu X, Huang G, Jin P. Clinicopathological and prognostic significance of aberrant G protein-couple receptor 110 (GPR110) expression in gastric cancer. Pathol Res Pract 2019;215:539-45. [PMID: 30638950 DOI: 10.1016/j.prp.2018.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
19 Feng Z, Qiao R, Ren Z, Hou X, Feng J, He X, Chen D. Could CTSK and COL4A2 be specific biomarkers of poor prognosis for patients with gastric cancer in Asia?-a microarray analysis based on regional population. J Gastrointest Oncol 2020;11:386-401. [PMID: 32399279 DOI: 10.21037/jgo.2020.03.01] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Mao C, Ma L, Huang Y, Yang X, Huang H, Cai W, Sitrakiniaina A, Gu R, Xue X, Shen X. Immunogenomic Landscape and Immune-Related Gene-Based Prognostic Signature in Asian Gastric Cancer. Front Oncol 2021;11:750768. [PMID: 34804939 DOI: 10.3389/fonc.2021.750768] [Reference Citation Analysis]
21 Bui Q, Grazziotin-soares D, Hasiniatsy RE, Trinh H, Richard S, Lotz J, Gligorov J, Khalil A. Cancer de l’estomac métastatique : les essais cliniques en Asie et en Occident. Bulletin du Cancer 2018;105:932-43. [DOI: 10.1016/j.bulcan.2018.07.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
22 Gong W, Zhao H, Liu S, Guan J, Liu X, Hou Q, Zhu Z, Guo H. Outcomes of radiation therapy for resectable M0 gastric cancer. Oncotarget 2018;9:1726-34. [PMID: 29416726 DOI: 10.18632/oncotarget.22574] [Reference Citation Analysis]
23 Jia S, Lu J, Qu T, Feng Y, Wang X, Liu C, Ji J. MAGI1 inhibits migration and invasion via blocking MAPK/ERK signaling pathway in gastric cancer. Chin J Cancer Res 2017;29:25-35. [PMID: 28373751 DOI: 10.21147/j.issn.1000-9604.2017.01.04] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
24 Rana N, Gosain R, Lemini R, Wang C, Gabriel E, Mohammed T, Siromoni B, Mukherjee S. Socio-Demographic Disparities in Gastric Adenocarcinoma: A Population-Based Study. Cancers (Basel) 2020;12:E157. [PMID: 31936436 DOI: 10.3390/cancers12010157] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
25 Cao LL, Lu J, Li P, Xie JW, Wang JB, Lin JX, Chen QY, Lin M, Tu RH, Zheng CH, Huang CM. Evaluation of the Eighth Edition of the American Joint Committee on Cancer TNM Staging System for Gastric Cancer: An Analysis of 7371 Patients in the SEER Database. Gastroenterol Res Pract 2019;2019:6294382. [PMID: 31097961 DOI: 10.1155/2019/6294382] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
26 Agolli L, Nicosia L. Between evidence and new perspectives on the current state of the multimodal approach to gastric cancer: Is there still a role for radiation therapy? World J Gastrointest Oncol 2018; 10(9): 271-281 [PMID: 30254722 DOI: 10.4251/wjgo.v10.i9.271] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Hadzitheodorou C, Moss RA, Kennedy TJ, Jabbour SK. Neoadjuvant Chemotherapy and Adjuvant Chemoradiation Therapy in the Treatment of Resected Gastric Adenocarcinoma: A Case Series. Case Rep Oncol 2017;10:308-15. [PMID: 28512415 DOI: 10.1159/000464280] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
28 Banerjee S, Zhao B, Sicklick JK, Aslam S, Burgoyne AM, Kelly KJ. Commission on Cancer Facility Type is Associated with Overall Survival in Patients with Gastric Adenocarcinoma in the United States. Ann Surg Oncol 2021;28:2846-55. [PMID: 33389292 DOI: 10.1245/s10434-020-09422-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Kotzev AI, Draganov PV. Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 72-4 in Gastric Cancer: Is the Old Band Still Playing? Gastrointest Tumors. 2018;5:1-13. [PMID: 30574476 DOI: 10.1159/000488240] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
30 Balakrishnan M, George R, Sharma A, Graham DY. Changing Trends in Stomach Cancer Throughout the World. Curr Gastroenterol Rep 2017;19:36. [PMID: 28730504 DOI: 10.1007/s11894-017-0575-8] [Cited by in Crossref: 118] [Cited by in F6Publishing: 110] [Article Influence: 23.6] [Reference Citation Analysis]
31 Fugazzola P, Ansaloni L, Sartelli M, Catena F, Cicuttin E, Leandro G, De' Angelis GL, Gaiani F, Di Mario F, Tomasoni M, Coccolini F. Advanced gastric cancer: the value of surgery. Acta Biomed 2018;89:110-6. [PMID: 30561428 DOI: 10.23750/abm.v89i8-S.7897] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
32 Yu C, Zhang Y. Development and validation of a prognostic nomogram for early-onset colon cancer. Biosci Rep 2019;39:BSR20181781. [PMID: 31142625 DOI: 10.1042/BSR20181781] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
33 Li S, Li Z, Guo T, Xing XF, Cheng X, Du H, Wen XZ, Ji JF. Maternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in gastric cancer. Oncotarget. 2016;7:6266-6280. [PMID: 26701722 DOI: 10.18632/oncotarget.6673] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
34 Marrelli D, Polom K, Roviello F. Ethnicity-related differences in tumor immunity: a new possible explanation for gastric cancer prognostic variability? Transl Gastroenterol Hepatol 2016;1:11. [PMID: 28138578 DOI: 10.21037/tgh.2016.03.03] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
35 Kumar S, Metz DC, Ellenberg S, Kaplan DE, Goldberg DS. Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study.Gastroenterology. 2020;158:527-536.e7. [PMID: 31654635 DOI: 10.1053/j.gastro.2019.10.019] [Cited by in Crossref: 54] [Cited by in F6Publishing: 40] [Article Influence: 18.0] [Reference Citation Analysis]
36 Zhang J, Gan L, Xu MD, Huang M, Zhang X, Gong Y, Wang X, Yu G, Guo W. The prognostic value of age in non-metastatic gastric cancer after gastrectomy: a retrospective study in the U.S. and China. J Cancer 2018;9:1188-99. [PMID: 29675100 DOI: 10.7150/jca.22085] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
37 Liu N, Molena D, Stem M, Blackford AL, Sewell DB, Lidor AO. Underutilization of Treatment for Regional Gastric Cancer Among the Elderly in the USA. J Gastrointest Surg 2018;22:955-63. [PMID: 29404983 DOI: 10.1007/s11605-018-3691-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
38 Coccolini F, Montori G, Ceresoli M, Cima S, Valli MC, Nita GE, Heyer A, Catena F, Ansaloni L. Advanced gastric cancer: What we know and what we still have to learn. World J Gastroenterol 2016; 22(3): 1139-1159 [PMID: 26811653 DOI: 10.3748/wjg.v22.i3.1139] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
39 Liu J, Medina H, Reis IM, Sussman DA, Pinheiro PS. Disadvantages for non-Hispanic whites in gastric carcinoma survival in Florida. Cancer Causes Control 2020;31:815-26. [PMID: 32462560 DOI: 10.1007/s10552-020-01320-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Jia S, Qu T, Feng M, Ji K, Li Z, Jiang W, Ji J. Association of Wnt1-inducible signaling pathway protein-1 with the proliferation, migration and invasion in gastric cancer cells. Tumour Biol 2017;39:1010428317699755. [PMID: 28618940 DOI: 10.1177/1010428317699755] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
41 Tseng J, Miller JP, Johnson J, Waters K, Gangi A, Gong J, Burch M. Disparities and survival in newly diagnosed gastric cancer in Hispanic patients in the United States: a propensity score matched analysis. J Gastrointest Oncol 2021;12:1308-25. [PMID: 34532090 DOI: 10.21037/jgo-21-207] [Reference Citation Analysis]
42 Lin JX, Lin JP, Li P, Xie JW, Wang JB, Lu J, Chen QY, Cao LL, Lin M, Tu RH, Zheng CH, Huang CM. New metastatic lymph node classification for early gastric cancer should differ from those for advanced gastric adenocarcinoma: Results based on the SEER database. World J Clin Cases 2019; 7(2): 145-155 [PMID: 30705892 DOI: 10.12998/wjcc.v7.i2.145] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Jin H, Pinheiro PS, Callahan KE, Altekruse SF. Examining the gastric cancer survival gap between Asians and whites in the United States. Gastric Cancer. 2017;20:573-582. [PMID: 27866287 DOI: 10.1007/s10120-016-0667-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
44 Doi T, Iwasa S, Muro K, Satoh T, Hironaka S, Esaki T, Nishina T, Hara H, Machida N, Komatsu Y, Shimada Y, Otsu S, Shimizu S, Watanabe M. Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the JAVELIN Solid Tumor JPN trial. Gastric Cancer. 2019;22:817-827. [PMID: 30515672 DOI: 10.1007/s10120-018-0903-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
45 Krasniqi E, Pellicori S, Formica V. Emerging role of S-1 in gastric cancer. Indian J Med Paediatr Oncol 2015;36:219-28. [PMID: 26811591 DOI: 10.4103/0971-5851.171542] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
46 Laszkowska M, Tramontano AC, Kim J, Camargo MC, Neugut AI, Abrams JA, Hur C. Racial and ethnic disparities in mortality from gastric and esophageal adenocarcinoma. Cancer Med 2020;9:5678-86. [PMID: 32573964 DOI: 10.1002/cam4.3063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
47 Steffens D, Solomon MJ, Beckenkamp PR, Koh CE, Yeo D, Sandroussi C, Hancock MJ; Fit-4-Home Collaborators. Individualised, targeted step count intervention following gastrointestinal cancer surgery: The Fit-4-Home randomised clinical trial. ANZ J Surg 2021. [PMID: 34553480 DOI: 10.1111/ans.17212] [Reference Citation Analysis]
48 Ju T, Rivas L, Kurland K, Chen S, Sparks A, Lin PP, Vaziri K. National trends in total vs subtotal gastrectomy for middle and distal third gastric cancer. Am J Surg. 2020;219:691-695. [PMID: 31030990 DOI: 10.1016/j.amjsurg.2019.04.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
49 Biagioni A, Skalamera I, Peri S, Schiavone N, Cianchi F, Giommoni E, Magnelli L, Papucci L. Update on gastric cancer treatments and gene therapies. Cancer Metastasis Rev 2019;38:537-48. [PMID: 31486976 DOI: 10.1007/s10555-019-09803-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 20.5] [Reference Citation Analysis]
50 Kuipers EJ. Gastric Cancer: Synopsis and Epidemiology of Gastric Cancer. In: Kim N, editor. Helicobacter pylori. Singapore: Springer; 2016. pp. 241-9. [DOI: 10.1007/978-981-287-706-2_21] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
51 Wu X, Wu Y, Ye B, Wu F, Wang P. High expression of ghrelin and obestatin prepropeptide in tumor tissues predicted adverse overall survival in gastric carcinoma patients. Medicine (Baltimore) 2020;99:e20635. [PMID: 32590738 DOI: 10.1097/MD.0000000000020635] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
52 Wang X, Zhao J, Shen Z, Fairweather M, Enzinger PC, Sun Y, Wang J. Multidisciplinary Approach in Improving Survival Outcome of Early-Stage Gastric Cancer. J Surg Res 2020;255:285-96. [PMID: 32574755 DOI: 10.1016/j.jss.2020.05.058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
53 Zhou D, Wu Y, Zhu Y, Lin Z, Yu D, Zhang T. The Prognostic Value of Neutrophil-to-lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Metastatic Gastric Cancer Treated with Systemic Chemotherapy. J Cancer 2020;11:4205-12. [PMID: 32368303 DOI: 10.7150/jca.39575] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
54 Ikoma N, Blum M, Chiang YJ, Estrella JS, Roy-Chowdhuri S, Fournier K, Mansfield P, Ajani J, Badgwell BD. Race Is a Risk for Lymph Node Metastasis in Patients With Gastric Cancer. Ann Surg Oncol 2017;24:960-5. [PMID: 27778127 DOI: 10.1245/s10434-016-5645-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
55 Zheng X, Mao X, Xu K, Lü L, Peng X, Wang M, Xu G, Hua Z, Wang J, Xue H, Wang J, Lu C. Massive Endoscopic Screening for Esophageal and Gastric Cancers in a High-Risk Area of China. PLoS One 2015;10:e0145097. [PMID: 26699332 DOI: 10.1371/journal.pone.0145097] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
56 Zhang C, Zhang C, Wang Q, Li Z, Lin J, Wang H. Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types. JAMA Netw Open 2020;3:e202950. [PMID: 32267515 DOI: 10.1001/jamanetworkopen.2020.2950] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
57 Mueller JL, Kim DH, Stapleton S, Cauley CE, Chang DC, Park CH, Song KY, Mullen JT. Nature versus nurture: the impact of nativity and site of treatment on survival for gastric cancer. Gastric Cancer 2019;22:446-55. [PMID: 30167904 DOI: 10.1007/s10120-018-0869-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
58 Chen XD, Mao CC, Wu RS, Zhang WT, Lin J, Sun XW, Chi CH, Lou N, Wang PF, Shen X, Zhu GB, Shen SR. Use of the combination of the preoperative platelet-to-lymphocyte ratio and tumor characteristics to predict peritoneal metastasis in patients with gastric cancer. PLoS One 2017;12:e0175074. [PMID: 28384215 DOI: 10.1371/journal.pone.0175074] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]